KR870002835A - 이온화성 소수성약제의 약제학적 제조방법 - Google Patents

이온화성 소수성약제의 약제학적 제조방법 Download PDF

Info

Publication number
KR870002835A
KR870002835A KR1019860007750A KR860007750A KR870002835A KR 870002835 A KR870002835 A KR 870002835A KR 1019860007750 A KR1019860007750 A KR 1019860007750A KR 860007750 A KR860007750 A KR 860007750A KR 870002835 A KR870002835 A KR 870002835A
Authority
KR
South Korea
Prior art keywords
agent
pharmaceutical preparation
hydrophobic drug
emulsifier
physiological
Prior art date
Application number
KR1019860007750A
Other languages
English (en)
Other versions
KR890004684B1 (ko
Inventor
라구나스지 데사이 나렌드라
가네산 마두라이
앨버트 카아펀티어 유지인
차알즈 샤이널 에드워드
Original Assignee
죤 제이 헤이간
아메리칸 사이아나밋드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죤 제이 헤이간, 아메리칸 사이아나밋드 캄파니 filed Critical 죤 제이 헤이간
Publication of KR870002835A publication Critical patent/KR870002835A/ko
Application granted granted Critical
Publication of KR890004684B1 publication Critical patent/KR890004684B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

이온화성 소수성약제의 약제학적 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1도는 물속에서의 비스안트렌의 용해도를 나타내는 도면,
제 2도는 선택된 매체 및 생물학적 유체내에서의 비스안트렌의 용해도를 나타내는 도면이다

Claims (1)

  1. 소수성 약제를, 약제학적으로 만족스러운 유성 부형제 또는 오일 ; 계면활성제 또는 유화제 ; 조계면 활성제 또는 보조유화제 및 문제의 약제에 대해 조용매로 기능하기에 충분한 벤질알코올과 결합시키는 단계들을 특징으로 하며, 소수성 약제는 물에 잘 녹지 않는 이온화성 교체 또는 불수용성 점성 유영 액체일수 있고 생리학적 pH 이하 또는 근처의 이온화상수를 갖는 염기성 약제이거나 생리학적 pH이상 또는 근처의 이온화상수를 갖는 산성약제일 수 있는, 소수성 약제의 약제학적 조성물의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860007750A 1985-09-16 1986-09-15 소수성약제의 전달용 약제학적 조성물 KR890004684B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US776,306 1985-09-16
US06/776,306 US4784845A (en) 1985-09-16 1985-09-16 Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs

Publications (2)

Publication Number Publication Date
KR870002835A true KR870002835A (ko) 1987-04-13
KR890004684B1 KR890004684B1 (ko) 1989-11-25

Family

ID=25107019

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860007750A KR890004684B1 (ko) 1985-09-16 1986-09-15 소수성약제의 전달용 약제학적 조성물

Country Status (18)

Country Link
US (1) US4784845A (ko)
EP (1) EP0215313B1 (ko)
JP (1) JPS6267018A (ko)
KR (1) KR890004684B1 (ko)
AR (1) AR242716A1 (ko)
AT (1) ATE78683T1 (ko)
AU (1) AU591705B2 (ko)
CA (1) CA1272447A (ko)
DE (1) DE3686221T2 (ko)
DK (1) DK165730C (ko)
ES (1) ES2002750A6 (ko)
FI (1) FI863728A (ko)
GR (1) GR862354B (ko)
HU (1) HU199282B (ko)
NO (1) NO863670L (ko)
NZ (1) NZ217484A (ko)
PH (1) PH23736A (ko)
ZA (1) ZA867009B (ko)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4820724A (en) * 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
GB8714652D0 (en) * 1987-06-23 1987-07-29 Davis S S Drug emulsion
US5229422A (en) * 1987-09-07 1993-07-20 Teijin Limited Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
NZ227813A (en) * 1988-02-10 1990-03-27 Richardson Vicks Inc Oil in water emulsion having 3-40% oil and an amphipathic emulsifying agent in the range 0.02-2% and method of forming such emulsions
EP0406275A4 (en) * 1988-03-21 1992-05-06 Daratech Pty. Ltd. Teat dip
AU622664B2 (en) * 1988-03-21 1992-04-16 Daratech Pty Ltd Teat dip
EP0361928B1 (en) * 1988-09-29 1994-04-27 Shiseido Company Limited Emulsified composition
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
US5004593A (en) * 1989-04-17 1991-04-02 Mayo Foundation For Medical Education And Research Hexamethylmelamine formulation exhibiting reduced neurotoxicity
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
EP0556392A4 (en) * 1990-11-06 1994-03-17 Nippon Shinyaku Co Ltd PROCESS FOR PRODUCING A FATTY EMULSION.
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
IL103275A0 (en) * 1991-10-01 1993-02-21 Lilly Co Eli Injectable extended release formulations and methods
JPH06245700A (ja) * 1993-02-23 1994-09-06 Snow Brand Milk Prod Co Ltd 消化吸収性を低減した油脂組成物
WO1994028872A1 (en) * 1993-06-04 1994-12-22 Warner-Lambert Company Non-alcoholic cold and sinus medication
PL178397B1 (pl) * 1994-02-04 2000-04-28 Scotia Lipidteknik Ab Emulsja typu olej w wodzie i środek farmaceutyczny zawierający emulsję typu olej w wodzie
HUT74735A (en) * 1994-02-25 1997-02-28 Takeda Chemical Industries Ltd Injectable emulsion composition containing antifungal triazole derivatives and process for producing it
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
DE69535127T2 (de) * 1994-03-18 2007-02-15 Supernus Pharmaceuticals, Inc. Emulgierte arzneistoffabgabesysteme
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
AU713580B2 (en) * 1995-09-25 1999-12-02 Merial Ltd Anthelmintic macrocyclic lactone compositions
AU728221B2 (en) 1996-06-05 2001-01-04 Ashmont Holdings Limited Injectable compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
CA2304568C (en) * 1997-09-30 2008-08-12 Eli Lilly And Company Olanzapine pamoate formulations
US6036946A (en) 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
WO1999043301A1 (en) * 1998-02-24 1999-09-02 The Board Of Trustees Of The University Of Illinois Lipid emulsions in the treatment of systemic poisoning
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
US6777450B1 (en) * 2000-05-26 2004-08-17 Color Access, Inc. Water-thin emulsions with low emulsifier levels
CA2469119A1 (en) * 2001-12-03 2003-06-12 Novacea, Inc. Pharmaceutical compositions comprising active vitamin d compounds
AU2002353118A1 (en) * 2001-12-11 2003-07-24 Dor Biopharma, Inc. Lipid particles and suspensions and uses thereof
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040062779A1 (en) * 2002-09-26 2004-04-01 Jerry Whittemore Dermatologic composition using ultra-fine/micronized 1-ascorbic acid and other antioxidant ingredients in a stabilized anhydrous vehicle
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050186230A1 (en) * 2004-01-23 2005-08-25 Sd Pharmaceuticals, Inc. Elemene compositions containing liquid oil
PL1838716T3 (pl) 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
KR101327649B1 (ko) * 2005-03-31 2013-11-12 산토리 홀딩스 가부시키가이샤 리그난류 화합물 함유 수중 유적형 에멀션 및 그것을함유하는 조성물
CN101547687A (zh) * 2005-11-17 2009-09-30 生物药效率有限公司 生物相容的潜在乳化剂
CN101511356A (zh) * 2006-10-04 2009-08-19 三得利株式会社 含有木脂素类化合物的o/w/o型乳液及含有该乳液的组合物
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
NZ590141A (en) * 2008-06-24 2012-05-25 Merial Ltd Anthelminthic formulations including castor oil and another vegetable oil
KR20160099081A (ko) 2013-07-26 2016-08-19 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조합 방법
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CA3073527A1 (en) * 2017-09-12 2019-03-21 Academic Pharmaceuticals, Inc. Metolazone emulsion formulation
US20210401775A1 (en) * 2018-11-02 2021-12-30 Amaterasu Lifesciences Llp A liquid injectable composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3116203A (en) * 1962-03-14 1963-12-31 Hoffmann La Roche Oleaginous systems
US3172816A (en) * 1963-01-28 1965-03-09 Smith Kline French Lab Method of increasing the oil solubility of compounds and products thereof
US3647624A (en) * 1969-07-24 1972-03-07 Wisconsin Alumni Res Found Treatment of blood with oleaginous substance
US4124720A (en) * 1970-11-09 1978-11-07 Wenmaekers Georges E J Therapeutic hydrodispersible emulsion
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
FR2313078A1 (fr) * 1975-02-07 1976-12-31 Anvar Composition a base d'huile vegetale metabolisable et d'eau, utilisable notamment pour la constitution de preparations adjuvantes, ces preparations adjuvantes et leur procede d'obtention
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate
US3991206A (en) * 1976-01-15 1976-11-09 American Cyanamid Company Alleviation of eye inflammation by topical application of p-biphenylacetic acid
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
ES484296A1 (es) * 1978-09-22 1980-10-01 Unilever Nv Un procedimiento de preparacion de una emulsion de agua en aceite adecuados para la preparacion de cosmeticos, farma- cos y otros productos.
US4340054A (en) * 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤
JPS59134710A (ja) * 1983-01-21 1984-08-02 Suntory Ltd 発酵養毛化粧料
US4563354A (en) * 1983-10-26 1986-01-07 Kabivitrum Ab Oil-in-water emulsion for parenteral administration
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 4−ビフエニリル酢酸系化合物含有脂肪乳剤
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs

Also Published As

Publication number Publication date
CA1272447A (en) 1990-08-07
DK438286D0 (da) 1986-09-12
HU199282B (en) 1990-02-28
NO863670L (no) 1987-03-17
NO863670D0 (no) 1986-09-15
DK165730B (da) 1993-01-11
HUT43947A (en) 1988-01-28
AU591705B2 (en) 1989-12-14
NZ217484A (en) 1990-04-26
PH23736A (en) 1989-11-03
DE3686221D1 (de) 1992-09-03
AU6269686A (en) 1987-03-19
JPS6267018A (ja) 1987-03-26
EP0215313A2 (en) 1987-03-25
ES2002750A6 (es) 1988-10-01
US4784845A (en) 1988-11-15
DK165730C (da) 1993-06-07
GR862354B (en) 1987-01-19
AR242716A1 (es) 1993-05-31
KR890004684B1 (ko) 1989-11-25
ZA867009B (en) 1987-07-29
FI863728A (fi) 1987-03-17
EP0215313B1 (en) 1992-07-29
EP0215313A3 (en) 1987-09-09
DE3686221T2 (de) 1993-02-25
ATE78683T1 (de) 1992-08-15
DK438286A (da) 1987-03-17
FI863728A0 (fi) 1986-09-15

Similar Documents

Publication Publication Date Title
KR870002835A (ko) 이온화성 소수성약제의 약제학적 제조방법
KR870002834A (ko) 유제조성물의 제조방법
DK312583D0 (da) Kortikoidholdigt praeparat til topisk applikation
ATE497384T1 (de) Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
NO20031249L (no) Emulsjonspreparater samt konsentrater derav
NO995367L (no) Aktivert Vitamin D3-emulsjonstype losjoner
DE69727849D1 (de) Cyclosporin-Emulsionen
KR830002327A (ko) 약학적 제제
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
NO308448B1 (no) Mikrosfærer samt fremstilling, preparater og anvendelse derav
AR020288A1 (es) Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado.
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
CY1108659T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ενα αμφοτερικο επιφανειοδραστικο, μια πολυπροποξυλιωμενη κετυλικη αλκοολη και μια πολικη φαρμακευτικη ουσια
PT743860E (pt) Preparacao de microcapsulas ocas
DE59008336D1 (de) Orale Lipidarzneiform.
MA23344A1 (fr) Nouvelles compositions d'emulsions
DE59909759D1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
KR930001929A (ko) 안과용 조성물
NO20024194D0 (no) Nytt selvemulgerende legemiddelavleveringssystem
FR2706298B1 (fr) Composition cosmétique ou dermatologique sous forme d'une émulsion huile-dans-l'eau stable contenant au moins une huile végétale constituée d'au moins 40% de triglycérides d'acide linoléique.
KR900012613A (ko) 경구 투여용 의약조성물
DE59711745D1 (de) Schaumförmige Zubereitungen mit einem Gehalt an grenzflächenaktiven Substanzen und Elektrolyten
KR920007620A (ko) 실리마린 및 약학 또는 화장품조성물의 용해방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19931005

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee